SunTrust Robinson Humphrey Starts Dicerna Pharmaceuticals (DRNA) at Buy

February 5, 2018 6:06 AM

SunTrust Robinson Humphrey initiates coverage on Dicerna Pharmaceuticals (NASDAQ: DRNA) with a Buy rating and a price target of $13.00.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found